On 2026-07-20, Bristol Myers Squibb (BMS) announced the deployment of its second NVIDIA DGX SuperPOD, further advancing its AI capabilities in the life sciences industry. This expansion builds one of the most advanced AI factories in the sector, leveraging NVIDIA's technology.
Source preview
Server-side extracted preview paragraphs from the original source.
Erin Davis calls it the “SuperDuperPOD.” That’s two things in one name: pharmaceutical giant Bristol Myers Squibb (BMS) already runs one of the largest AI clusters in life sciences, with serious results to show for it.
The source did not expose a stable full-text body. The complete AI BriefWire briefing is available above; use Read original for the full source article.